Natural News | Jan 25, 2012

By Ethan A. Huff

(NaturalNews) The US Food and Drug Administration (FDA) has approved a new cancer drug that allegedly treats the deadly side effects caused by another popular cancer drug. The new drug, Voraxaze (glucarpidase), is said to expel methotrexate, a commonly prescribed and highly toxic chemotherapy drug, from the body. But Voraxaze comes with its own set of harmful side effects, which shows that approving drugs to treat the side effects of other drugs is an endless, but highly profitable, cycle of toxicity.

Methotrexate’s known side effects include kidney and liver destruction, skin rashes, mouth sores, damaged intestines, and death. The drug often lingers in the body following cancer treatments, as weakened organs become increasingly incapable of expelling it from the body. So to “fix” this problem, the FDA has decided to approve another drug that it says breaks down methotrexate and eliminates it from the system.